# IQVIA Pty Ltd

Organization · id `cardio:org-iqvia-pty-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=IQVIA+Pty+Ltd>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: IQVIA Pty Ltd
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension (`cardio:ct-nct03254446`)
- Sponsors: Electrocardiogram Clinical Validation Study (`cardio:ct-nct03492554`)
- Sponsors: Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System (`cardio:ct-nct04201132`)
- Sponsors: ECG App Algorithms Clinical Validation Study (`cardio:ct-nct04247581`)
- Sponsors: Atrial Fibrillation Algorithms Clinical Validation Study (`cardio:ct-nct04699812`)
- Sponsors: Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients (`cardio:ct-nct05761444`)
- Sponsors: THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension (`cardio:ct-nct06559891`)

## Provenance

Content hash: 185d8291584b054e6e5bfc5c1d76ce4bd2940816d98e8d8af679750d9cff2356
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
